Evaluation of the effect of empagliflozin on prevention of atrial fibrillation after coronary artery bypass grafting: A double-blind, randomized, placebo-controlled trial
batool zarei,
Benyamin Fazli,
Mohammad Tayyebi
et al.
Abstract:Purpose
This study aimed to evaluate the effect of empagliflozin in preventing atrial fibrillation after coronary artery bypass grafting (CABG).
Methods
Eighty-two patients who fulfilled the inclusion criteria were allocated to the empagliflozin group (n = 43) or placebo group (n = 39). In two groups, patients received empagliflozin or placebo tablets three days before surgery and on the first three postoperative days (for six days) in addition to the standard regimen during hospitalization. During the first… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.